Tag: biosimilar approval

Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2026
Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2026

Explore how the FDA reviews biosimilars under the new 2025 guidance. Learn about the shift from clinical trials to analytical characterization, interchangeability rules, and what this means for patient access and drug costs.

Read More
FDA Listing for Biosimilars: How They Are Evaluated and Approved
FDA Listing for Biosimilars: How They Are Evaluated and Approved

The FDA doesn't rate biosimilars like generics-it evaluates them through a rigorous scientific process to prove they're highly similar and safe. Learn how biosimilars are approved, why they're different from generics, and what the Purple Book means for patients.

Read More

Latest Posts

Contact Us

SEND MESSAGE